Wednesday, October 14, 2015 8:20:05 PM
Management will hold a conference call as previously scheduled on November 4, 2015 starting at 4:30 p.m. (Eastern Time). The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com by navigating to "Our Company," then "Investor Relations," and then "Events and Webcasts," and will be archived for future reference. To listen to the conference call, please dial (888) 771-4371 (US/Canada) or (847) 585-4405 (International) and use the confirmation number "40455195" approximately five minutes prior to the start time
Recent DXCM News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 09:15:16 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/28/2026 08:10:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:39:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:39:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:39:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:39:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 08:38:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:18:26 PM
- Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users • Business Wire • 05/26/2026 01:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2026 09:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:34:28 PM
- Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany • Business Wire • 05/18/2026 11:31:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2026 08:05:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:39:16 PM
- Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day • Business Wire • 05/14/2026 08:02:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 01:47:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:02 PM
- Dexcom to Host Investor Day on May 14, 2026 • Business Wire • 05/05/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 09:20:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:02:43 PM
- Dexcom Reports First Quarter 2026 Financial Results • Business Wire • 04/30/2026 08:02:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 10:24:53 PM
